Deutsch English Français

Contact

EP0007412

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...

Extract from the Register of European Patents

EP About this file: EP0007412

EP0007412 - Utilisation of 2-(N-(2,6-dichloro-phenyl)-N-allyl-amino)-imidazoline-(2) for the production of bradycardiac drugs [Right-click to bookmark this link]
Former [1980/03]	Utilisation of 2-(N-(2,6-dichloro-phenyl)-N-allyl-amino)-imidazoline-(2) as a bradycardiac drug
	[1987/09]
Status	No opposition filed within time limit Status updated on 18.12.1987 Database last updated on 11.04.2026
Most recent event Tooltip	12.11.1999	Lapse of the patent in a contracting state	published on 29.12.1999 [1999/52]
Applicant(s)	For all designated states C.H. BOEHRINGER SOHN Postfach 200 D-6507 Ingelheim am Rhein / DE
	[1980/03]
Inventor(s)	01 / Stähle, Helmut, Dr. Rotweinstrasse 23 D-6507 Ingelheim / DE
	02 / Köppe, Herbert, Dr. Neuweg 72 D-6507 Ingelheim / DE
	03 / Kummer, Werner, Dr. Georg-Scheuing-Strasse 15 D-6507 Ingelheim / DE
	04 / Arndts, Dietrich, Dr. Mühlstrasse 7 D-6531 Appenheim / DE
	05 / Kobinger, Walter, Prof. Dr. Belghofergasse 27 A-1120 Wien / AT
	06 / Lillie, Christian, Dr. Hansi-Niese-Weg 12 A-1130 Wien / AT
	07 / Pichler, Ludwig, Dr. Gusshausstrasse 24 A-1040 Wien / AT
	[1980/03]
Application number, filing date	79101874.0	11.06.1979
	[1980/03]
Priority number, date	DE19782831190	15.07.1978 Original published format: DE 2831190
	[1980/03]
Filing language	DE
Procedural language	DE
Publication	Type:	A1 Application with search report
	No.:	EP0007412
	Date:	06.02.1980
	Language:	DE
	[1980/03]
	Type:	B1 Patent specification
	No.:	EP0007412
	Date:	25.02.1987
	Language:	DE
	[1987/09]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	19.11.1979
Classification	IPC:	A61K31/415	[1980/03]
	CPC:	A61K31/415 (EP,US); A61P9/00 (EP); A61P9/10 (EP)
Designated contracting states	AT, BE, CH, DE, FR, GB, IT, LU, NL, SE [1980/03]
Title	German:	Verwendung von 2-(N-(2,6-Dichlorphenyl)-N-allyl-amino)-imidazolin-(2) zur Herstellung von bradykarden Arzneimitteln	[1987/09]
	English:	Utilisation of 2-(N-(2,6-dichloro-phenyl)-N-allyl-amino)-imidazoline-(2) for the production of bradycardiac drugs	[1987/09]
	French:	Application de la 2-(N-(2,6-dichloro-phényl)-N-allyl-amino)-imidazoline-(2) pour la fabrication de médicaments bradycardiaques	[1987/09]
	Former [1980/03]	Verwendung von 2-(N-(2,6-Dichlorphenyl)-N-allyl-amino)-imidazolin-(2) als bradykardes Mittel
	Former [1980/03]	Utilisation of 2-(N-(2,6-dichloro-phenyl)-N-allyl-amino)-imidazoline-(2) as a bradycardiac drug
	Former [1980/03]	Application de la 2-(N-(2,6-dichloro-phényl)-N-allyl-amino)-imidazoline-(2) comme médicament bradycardiaque
Examination procedure	07.08.1979	Examination requested [1980/03]
	10.11.1980	Despatch of a communication from the examining division (Time limit: M02)
	17.12.1980	Reply to a communication from the examining division
	10.11.1982	Despatch of a communication from the examining division (Time limit: M04)
	05.02.1983	Reply to a communication from the examining division
	10.07.1986	Despatch of communication of intention to grant (Approval: )
	21.08.1986	Communication of intention to grant the patent
	28.10.1986	Fee for grant paid
	28.10.1986	Fee for publishing/printing paid
Opposition(s)	26.11.1987	No opposition filed within time limit [1988/05]
Fees paid	Renewal fee
	11.05.1981	Renewal fee patent year 03
	25.06.1982	Renewal fee patent year 04
	11.06.1983	Renewal fee patent year 05
	12.06.1984	Renewal fee patent year 06
	13.06.1985	Renewal fee patent year 07
	12.06.1986	Renewal fee patent year 08
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	LU	30.06.1987
	[1999/52]
Cited in	Examination	Arzneimittelforschung, 25 (1975), 786-93
		Arzneimittelforschung, 16 (1966), 1038-50
		Arch. int. Pharmacodyn, 228 (1977), 237-50
		Arch. int. Pharmacodyn, 228 (1977), 251-67
		Hypertension and brain mechanisms. Progress in brain research. W. de Jong et al., Eds., Vol. 47, 391-96 (Elserier/North-Holland Biomedical Press, Amsterdam, 1977)
		J. Med. Chem., 23 (1980), 1217-22
		Naunyn-Schmiedeberg's Archives of Pharmacology, 307, Suppl. 1979, p. R40, R41
		Naunyn-Schmiedeberg's Archives of Pharmacology, 308, Suppl. 1979, p. R19
		European Journal of Pharmacology, 58 (1979), 141-50
		Naunyn-Schmiedeberg's Archives of Pharmacology, 306 (1979), 255-62

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.